{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T18:44:01Z","timestamp":1792608241421,"version":"4.5.0"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T00:00:00Z","timestamp":1689120000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>A 28-year-old female patient diagnosed with Ehlers-Danlos syndrome type III (hypermobile EDS, hEDS) was admitted to the cardiology clinic due to a 3-year history of symptomatic ventricular arrhythmia in the form of multiple premature ventricular contractions (PVCs). Attempts at antiarrhythmic treatment with beta-blockers, propafenone, and verapamil were unsuccessful. Due to the diagnosis of hEDS and the high risk of vascular complications related to the ablation procedure, invasive treatment was abandoned, and it was decided to implement flecainide. After the flecainide treatment initiation, a spectacular improvement in the number of ventricular arrhythmias was observed, along with the disappearance of the complaints previously reported by the patient. To the best of our knowledge, this is the first described case of spectacular flecainide antiarrhythmic effect in a patient with numerous PVCs also diagnosed with EDS. Flecainide treatment in the EDS group could be a successful alternative to ablation, which can lead to serious vascular and even life-threatening complications, especially after the failure of propafenone and beta-blockers treatment.<\/jats:p>","DOI":"10.3389\/fcvm.2023.1171541","type":"journal-article","created":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T19:19:44Z","timestamp":1689189584000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Therapeutic difficulties in a patient with Ehlers-Danlos syndrome and numerous symptomatic premature ventricular contractions\u2014case report and literature review"],"prefix":"10.3389","volume":"10","author":[{"given":"Grzegorz","family":"S\u0142awi\u0144ski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"El\u017cbieta","family":"Wabich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"Hawryszko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludmi\u0142a","family":"Dani\u0142owicz-Szymanowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Chevalier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,7,12]]},"reference":[{"key":"B1","first-page":"V01160014","article-title":"Ehlers-Danlos syndrome","volume":"178","author":"Leganger","year":"2016","journal-title":"Ugeskr Laeger"},{"key":"B2","doi-asserted-by":"publisher","first-page":"30","DOI":"10.7556\/jaoa.2020.012","article-title":"The many facets of hypermobile Ehlers-Danlos syndrome","volume":"120","author":"Riley","year":"2020","journal-title":"J Am Osteopath Assoc"},{"key":"B3","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/ajmg.c.31538","article-title":"Hypermobile Ehlers-Danlos syndrome (a.k.a. Ehlers-Danlos syndrome type III and Ehlers-Danlos syndrome hypermobility type): clinical description and natural history","volume":"175","author":"Tinkle","year":"2017","journal-title":". Am J Med Genet C Semin Med Genet"},{"key":"B4","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1002\/ajmg.c.31553","article-title":"Diagnosis, natural history, and management in vascular Ehlers-Danlos syndrome","volume":"175","author":"Byers","year":"2017","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"B5","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1097\/GIM.0b013e3181eed412","article-title":"Clinical and genetic aspects of Ehlers-Danlos syndrome, classic type","volume":"12","author":"Malfait","year":"2010","journal-title":"Genet Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1016\/j.jvs.2016.06.120","article-title":"Arterial complications of vascular Ehlers-Danlos syndrome","volume":"64","author":"Eagleton","year":"2016","journal-title":"J Vasc Surg"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e2789","DOI":"10.1210\/clinem\/dgab033","article-title":"Ehlers-Danlos syndrome: molecular and clinical characterization of TNXA\/TNXB chimeras in congenital adrenal hyperplasia","volume":"106","author":"Marino","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"B8","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/ajmg.c.31548","article-title":"Ehlers-Danlos syndrome, classical type","volume":"175","author":"Bowen","year":"2017","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1399-0004.2012.01858.x","article-title":"The Ehlers-Danlos syndrome, a disorder with many faces","volume":"82","author":"De Paepe","year":"2012","journal-title":"Clin Genet"},{"key":"B10","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1136\/archdischild-2013-304822","article-title":"Ehlers-Danlos syndrome: how to diagnose and when to perform genetic tests","volume":"100","author":"Sobey","year":"2015","journal-title":"Arch Dis Child"},{"key":"B11","doi-asserted-by":"publisher","first-page":"582","DOI":"10.21037\/acs.2017.11.03","article-title":"Differences in manifestations of Marfan syndrome, Ehlers-Danlos syndrome, and Loeys-Dietz syndrome","volume":"6","author":"Meester","year":"2017","journal-title":"Ann Cardiothorac Surg"},{"key":"B12","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/ajmg.c.31552","article-title":"The 2017 international classification of the Ehlers-Danlos syndromes","volume":"175","author":"Malfait","year":"2017","journal-title":"Am J Med Genet C Semin Med Genet."},{"key":"B13","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.hrcr.2018.03.008","article-title":"Arrhythmias and myocardial fragility in Ehlers-Danlos syndrome: complications after routine ICD placement","volume":"4","author":"Garg","year":"2018","journal-title":"HeartRhythm Case Rep"},{"key":"B14","doi-asserted-by":"publisher","first-page":"647","DOI":"10.2143\/AC.63.5.2033236","article-title":"Single-catheter approach for ablation of the slow pathway in a patient with type IV Ehlers-Danlos syndrome and AV nodal reentrant tachycardia using a magnetic navigation system","volume":"63","author":"Szili-Torok","year":"2008","journal-title":"Acta Cardiol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.hrcr.2021.12.007","article-title":"Ventricular tachycardia ablation in a patient with Ehlers-Danlos syndrome","volume":"8","author":"Calvert","year":"2021","journal-title":"HeartRhythm Case Rep"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1001\/archinte.1977.03630210093028","article-title":"Mitral valve prolapse and conduction defects in Ehlers-Danlos syndrome","volume":"137","author":"Cabeen","year":"1977","journal-title":"Arch Intern Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1590\/abd1806-4841.20153824","article-title":"Ehlers-Danlos syndrome associated with cardiomyopathy hypertrophic obstructive","volume":"90","author":"Pinto","year":"2015","journal-title":"An Bras Dermatol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1007\/s10067-014-2618-y","article-title":"Heart rate, conduction and ultrasound abnormalities in adults with joint hypermobility syndrome\/Ehlers-Danlos syndrome, hypermobility type","volume":"33","author":"Camerota","year":"2014","journal-title":"Clin Rheumatol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/j.recesp.2012.06.008","article-title":"Spanish catheter ablation registry. 11th official report of the Spanish society of cardiology working group on electrophysiology and arrhythmias (2011)","volume":"65","author":"D\u00edaz-Infante","year":"2012","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1136\/bcr.05.2009.1850","article-title":"Ehlers-Danlos syndrome","volume":"2009","author":"Choudhury","year":"2009","journal-title":"BMJ Case Rep"},{"key":"B21","doi-asserted-by":"publisher","first-page":"9161865","DOI":"10.1155\/2017\/9161865","article-title":"Orthostatic intolerance and postural orthostatic Tachycardia syndrome in joint hypermobility syndrome\/Ehlers-Danlos syndrome, hypermobility type: neurovegetative dysregulation or autonomic failure?","volume":"2017","author":"Celletti","year":"2017","journal-title":"Biomed Res Int"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2514","DOI":"10.1016\/S0735-1097(22)03505-7","article-title":"Management of refractory symptomatic premature ventricular contractions in a patient with Louis-Dietz syndrome type 3, Ehlers-Danlos syndrome, and Systemic lupus erythematosus","volume":"79","author":"Jaramillo","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"689","DOI":"10.2165\/11318030-000000000-00000","article-title":"Polymorphism of human cytochrome P450 2D6 and its clinical significance: part I","volume":"48","author":"Zhou","year":"2009","journal-title":"Clin Pharmacokinet"},{"key":"B24","doi-asserted-by":"publisher","first-page":"104443","DOI":"10.1016\/j.phrs.2019.104443","article-title":"Flecainide: electrophysiological properties, clinical indications, and practical aspects","volume":"148","author":"Paolini","year":"2019","journal-title":"Pharmacol Res"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e1178","DOI":"10.7759\/cureus.1178","article-title":"Brugada syndrome in a patient with vascular Ehlers-Danlos syndrome: sudden death risk amplified","volume":"9","author":"D'Souza","year":"2017","journal-title":"Cureus"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2023.1171541\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T19:19:48Z","timestamp":1689189588000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2023.1171541\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,12]]},"references-count":25,"alternative-id":["10.3389\/fcvm.2023.1171541"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2023.1171541","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,12]]},"article-number":"1171541"}}